1Ronco C, McCullough P, Anker SD, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative [J]. Eur Heart J, 2010, 31 (6) :703-711.
2Haase M, Mtiller C, Damman K, et al. Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI) for the Acute Dialysis Quality Initiative (ADQI) [J]. Contrib Nephrol, 2013, 182:99-116.
3Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome[J]. J Am Coil Cardiol, 2008, 52(19):1527-1539.
4Chan EJ, Dellsperger NC. Update on cardiorenal syndrome: a clinical conundrum [J]. Adv Petit Dial, 2011, 27:82-86.
5Cruz DN, Sehmidt-Ott KM, Veseovo G, et al. Pathophy- siology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI) [J]. Contrib Nephrol, 2013, 182:117-136.
6Fonarow GC, Adams KF Jr, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis[J]. JAMA , 2005,293(5) :572-580.
7Thomas Mueller , Benjamin , Dieplinger, et al. The Presage ST2 Assay: analytical considerations and clinical applications fora high-sensitivity assay for measurement of soluble ST2 [J]. Expert Rev Mol Diagn, 2003, 13(1) :13-30.
8Cruz DN, Goh CY, Haase-Fielitz A, et al. Early biomarkers of renal injury[J]. Congest Heart Fail, 2010, 16(Suppl 1): S25-S31.
9Zhu J, Yin R, Wu H, et al. Cystatin C as a reliable marker of renal function following heart valve replacement surgery with cardio-pulmonary bypass [J]. Clin Chim Acta, 2006, 374(1-2) : 116-121.
10Hawkins R. New biomarkers of acute kidney injury and the eardio-renal syndrome [J]. Korean J LabMed, 2011, 31 (2) : 72- 80.
5Ronco C, McCullough P, Anker SD ,et al. Cardio-renal syndromes : re- port from the consensus conference of the acrte dialysis quality initia- tive[J]. Eur Heart J, 2010,31(6) :703-711.
6Haase M, Mtiller C, Damman K, et al. Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgronp statements from the eleventh consensus conference of the Acute Dialy- sis Quality Initiative (ADQI) [ J]. Contrib Nephrol,2013 ,182 :99-116.
7Chou YH, Huang TM, Wu VC, et al. Impact of timing of renal re- placement therapy initiation on outcome of septic acute kidney injury [J]. Crit Care,2011,15(3): R134.
8《实用内科学》(2014版),人民卫生出版社,2014.
9Royston P,Altman DG.Risk stratification for in-hospital mortality in acutely decompensated heart failure[J].JAMA,2005,293(20):2467-2468.
10Volpe M,Rubattu S,Burnett J,et al.Natriuretic peptides in cardiovascular diseases:current use and perspectives[J].Eur Heart J,2014,35(7):419-425.
